Swen Hölder

Title: Swen Hölder: Innovator in Pharmaceutical Chemistry

Introduction

Swen Hölder is a notable inventor based in London, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target critical biological pathways. With a total of 5 patents to his name, Hölder's work has implications for various therapeutic applications.

Latest Patents

Among his latest patents, Hölder has developed innovative compounds such as Fused Bicyclic Imidazoles. These compounds are effective inhibitors of the Pi3K/Akt pathway, which is crucial in cancer research. Another notable patent is for Fused Pyrimidines, which also showcases his expertise in creating compounds with potential therapeutic benefits.

Career Highlights

Hölder has worked with prominent companies in the pharmaceutical industry, including Bayer Intellectual Property GmbH and Bayer Schering Pharma AG. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in drug development.

Collaborations

Throughout his career, Hölder has collaborated with esteemed colleagues such as Armin Zülch and Thomas Beckers. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.

Conclusion

Swen Hölder's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor in the industry. His work continues to pave the way for advancements in therapeutic compounds.